Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.
Bouhaddou M, Lee RH, Li H, Bhola NE, O'Keefe RA, Naser M, Zhu TR, Nwachuku K, Duvvuri U, Olshen AB, Roy R, Hechmer A, Bolen J, Keysar SB, Jimeno A, Mills GB, Vandenberg S, Swaney DL, Johnson DE, Krogan NJ, Grandis JR.
Bouhaddou M, et al. Among authors: roy r.
JCI Insight. 2021 Oct 22;6(20):e151982. doi: 10.1172/jci.insight.151982.
JCI Insight. 2021.
PMID: 34546978
Free PMC article.